πŸ‘οΈ8,960
GitHubLinkedIn
AI in Healthcare and Scienceβ€’β€’6 min readβ€’1196 words

πŸš€ Initiative W: Biological AI Safety and Therapeutic Design

πŸ‘οΈ0reads (human + AI)πŸ€–0AI ingestions
⚑Direct Technical Summary

Initiative W will focus on testing biological AI before release, in realistic research workflows, screening DNA/RNA by function, not only by sequence similarity, and building safet

πŸš€ Initiative W: Biological AI Safety and Therapeutic Design

Initiative W will focus on testing biological AI before release, in realistic research workflows, screening DNA/RNA by function, not only by sequence similarity, and building safety into AI-assisted therapeutic design.

Key Points:

  • Biological AI Safety: Initiative W aims to ensure the safety of biological AI systems by testing them in realistic research workflows before release.

  • Function-based Screening: The initiative will screen DNA/RNA by function, not just by sequence similarity, to identify potential risks and improve therapeutic design.

  • Therapeutic Design: Initiative W will focus on building safety into AI-assisted therapeutic design, ensuring that AI systems are designed to prioritize human safety and well-being.

πŸ”— Resources:

  • Original post β†—
  • Original source
  • Owkin Science
  • Initiative W: Biological AI Safety and Therapeutic Design

πŸ“Š Pan-RAS Inhibitors Landscape Update

August 2026 saw several notable developments across the Pan-RAS Inhibitors landscape, spanning regulatory milestones, clinical progress, corporate activity, and product launches.

Key Points:

  • Regulatory Milestones: The Pan-RAS Inhibitors landscape saw several regulatory milestones in August 2026, including FDA approvals and clinical trial updates.

  • Clinical Progress: Clinical trials for Pan-RAS Inhibitors made significant progress in August 2026, with several studies reporting positive results.

  • Corporate Activity: Corporate activity in the Pan-RAS Inhibitors space was also notable in August 2026, with several companies announcing partnerships and collaborations.

πŸ”— Resources:


🦠 New Virus Linked to Flu-like Illness and Low Platelets

15.1% of tick-bitten patients who tested negative for Dabie bandavirus were positive for a newly identified virus, ALTNV, linked to flu-like illness and low platelets.

Key Points:

  • New Virus Discovery: A new virus, ALTNV, has been linked to flu-like illness and low platelets in tick-bitten patients.

  • Prevalence: The virus was found in 15.1% of tick-bitten patients who tested negative for Dabie bandavirus.

  • Clinical Implications: The discovery of ALTNV has significant clinical implications for the diagnosis and treatment of tick-borne illnesses.

πŸ”— Resources:

  • Original post β†—
  • Original source
  • Medical Xpress
  • New Virus Linked to Flu-like Illness and Low Platelets

πŸ“ #WCLC26 Abstracts to Watch

10 #WCLC26 abstracts beyond the presidentials to watch: 1. FURVENT 2. TRIDENT-3 3. Iza-bren 4. BNT324-01 5. DeLLphi-309 6. DeLLphi-308 7. LONESTAR 8. Brain SRT + Osimertinib 9. BRAF + Immunotherapy 10. Tumor Budding.

Key Points:

  • #WCLC26 Abstracts: The #WCLC26 conference featured several notable abstracts, including FURVENT, TRIDENT-3, and Iza-bren.

  • Clinical Trials: Several of the abstracts presented clinical trial data, including DeLLphi-309 and DeLLphi-308.

  • Therapeutic Strategies: The abstracts also presented various therapeutic strategies, including Brain SRT + Osimertinib and BRAF + Immunotherapy.

πŸ”— Resources:


πŸŽ‰ Labor Day Celebration

Happy Labor Day, everyone! πŸ‡ΊπŸ‡ΈπŸ I’m biased, of course, being on the board of Health2Tech. But the event we have coming up this Thursday, Sept 10, in NYC near Penn Station is shaping up to be just outstanding.

Key Points:

  • Health2Tech Event: The Health2Tech event is scheduled for this Thursday, Sept 10, in NYC near Penn Station.

  • Women Investors: The event will feature a panel of women investors in healthcare and AI.

  • Networking Opportunity: The event provides a great opportunity for networking and learning about the latest developments in healthcare and AI.

πŸ”— Resources:


🧬 Gut Fungus Reduces Radiation-related Intestinal Injury

A gut fungus reduced radiation-related intestinal injury in mice, helping damaged cells repair DNA and restoring barrier function through three amino acids and a shift in bacterial metabolism.

Key Points:

  • Gut Fungus Discovery: A gut fungus has been found to reduce radiation-related intestinal injury in mice.

  • Mechanism: The fungus helps damaged cells repair DNA and restore barrier function through three amino acids and a shift in bacterial metabolism.

  • Clinical Implications: The discovery has significant clinical implications for the treatment of radiation-related injuries.

πŸ”— Resources:

  • Original post β†—
  • Original source
  • Medical Xpress
  • Gut Fungus Reduces Radiation-related Intestinal Injury

πŸ’‘ #camizestrant Approval

We're all hearing about the #camizestrant approval, so here are my two cents. The FDA cleared it in HR+/HER2- advanced breast cancer for patients who develop an ESR1 mutation in ctDNA on first-line endocrine therapy, before the scan progresses.

Key Points:

  • #camizestrant Approval: The FDA has approved #camizestrant for the treatment of HR+/HER2- advanced breast cancer.

  • Clinical Indication: The approval is for patients who develop an ESR1 mutation in ctDNA on first-line endocrine therapy, before the scan progresses.

  • Clinical Implications: The approval has significant clinical implications for the treatment of advanced breast cancer.

πŸ”— Resources:


πŸ“š T-5 to #WCLC26

T-5 to #WCLC26 β€” and the global oncologists have done the homework for each other: πŸ“š @M_Torasawa built a Notion database of the meeting: 210 Plenary, Oral & Mini Oral presentations, 181 abstract summaries.

Key Points:

  • #WCLC26 Database: @M_Torasawa has built a Notion database of the #WCLC26 meeting, featuring 210 Plenary, Oral & Mini Oral presentations and 181 abstract summaries.

  • Clinical Trials: The database provides a comprehensive overview of the clinical trials presented at the meeting.

  • Therapeutic Strategies: The database also presents various therapeutic strategies discussed at the meeting.

πŸ”— Resources:


🦠 Atherosclerosis May Meet Key Criteria for Autoimmune Disease

Atherosclerosis may meet key criteria for autoimmune disease: in mice, transferring high-affinity autoantibodies sped plaque buildup, and a histone 2B target emerged in evidence that also included 495 patients.

Key Points:

  • Atherosclerosis and Autoimmune Disease: Atherosclerosis may meet key criteria for autoimmune disease, according to a study in mice.

  • Mechanism: The study found that transferring high-affinity autoantibodies sped plaque buildup in mice.

  • Clinical Implications: The discovery has significant clinical implications for the treatment of atherosclerosis.

πŸ”— Resources:

  • Original post β†—
  • Original source
  • Medical Xpress
  • Atherosclerosis May Meet Key Criteria for Autoimmune Disease

🎯 Design Engineer Wanted

Hiring a Design Engineer to help build products for AI Γ— Biology. Our mission is to advance humanity’s ability to engineer biology. We approach this by understanding and improving AI’s application to biology use cases such as therapeutics and biosecurity.

Key Points:

  • Design Engineer Position: We are hiring a Design Engineer to help build products for AI Γ— Biology.

  • Mission: Our mission is to advance humanity’s ability to engineer biology.

  • AI Γ— Biology: We approach this by understanding and improving AI’s application to biology use cases such as therapeutics and biosecurity.

πŸ”— Resources:

πŸ“‚Source / Implementation:AI in Healthcare and Science / resources-244.md
GitHub Repository↗

Related AI in Healthcare and Science Breakdowns

Drishtant Ghosh (Drix10)
Drishtant Ghosh (Drix10)β€’Author & Engineer

Technical founder and engineer working across AI systems, developer infrastructure, and cybersecurity.